What do I need to know about Johnson & Johnson’s Janssen COVID-19 Vaccine (J&J/Janssen) now?

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  There is a risk of a rare but serious condition involving blood clots and low platelets in people after receiving the J&J/Janssen COVID-19 Vaccine. This risk is very low.
  
  This problem is rare and happened in about 7 per 1 million vaccinated women between 18 and 49 years old.
  
  For women 50 years and older and men of any age, this problem is even more rare.
  
  This problem has not been linked to the other two COVID-19 vaccines (Pfizer-BioNTech and Moderna).
  
  Learn more by talking with your doctor, nurse, or pharmacist, or visit the CDC website: www.cdc.gov.
  
  CS324167-A | April 28, 2021 11:56 AM
  
  324167-a-consumer-facing-three-vaccines-8.5x11-final-print.pdf
  
  
• Subjects:
  Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19 Vaccines/adverse Effects COVID-19/prevention & Control
• Document Type:
  Poster
• Name as Subject:
  Janssen COVID-19 Vaccine
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:71eae261434342f5c1b519e133f5ebe8c71bcb3a1d2adbdd9b98b13e3ecfab64
• Download URL:
  https://stacks.cdc.gov/view/cdc/105674/cdc_105674_DS1.pdf
• File Type:
  [PDF - 210.55 KB ]